GgoogleGB first seen 9 h ago, last 5 h ago, peak #3
Eli Lilly's retatrutide shows major weight loss in trials
Original: retatrutide
Eli Lilly's experimental drug retatrutide is drawing global attention after new trial results showed people lost up to 25% of their body weight, with patients who have Type 2 diabetes shedding as much as 60 pounds, or roughly 21% of their weight. Outlets including Reuters, NBC News and Ars Technica describe it as potentially the most powerful obesity drug yet, and searches are spiking in the US, UK and Brazil.
Why now: Newly published trial results showing unprecedented weight loss are driving widespread interest in the drug.
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 5 h ago.
Evidence
- Most powerful obesity drug yet: People lost up to 25% of weight in trial · Ars Technica
- People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug · NBC News
- Lilly's experimental drug cuts weight by 21% in diabetes trial · Reuters
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/416929